87/100BAmetek stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Ametek is 284.89, 24.6% above the current price of 228.62. Their targets range from 255.00 to 316.00.
Of the 13 firms that rated Ametek in the past 12 months, 8 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 255.00 to 316.00, with an average of 284.89.
| Buy | 8 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 316.00 |
| Average target | 284.89 |
| Lowest target | 255.00 |
| Current price | 228.62 |
Ametek price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Ametek price target and rating?
How analysts rate Ametek, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
8 of 13 firms rate it buy now, against 6 of 9 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Ametek analyst upgrades, downgrades and price targets
The latest rating change came on 27 January 2026, when Oppenheimer downgraded Ametek from Outperform to Perform. The most recent new target came from RBC Capital on 4 November 2026: 308.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 4 Nov 2026 | RBC Capital Jeffrey Reive | Reiterated · Outperform | 291.00 → 308.00 | +5.8% | 234.53 |
| 9 Oct 2026 | Morgan Stanley Christopher Snyder | — | 245.00 → 275.00 | +12.2% | 248.83 |
| 7 Oct 2026 | D.A. Davidson Matt Summerville | — | 240.00 → 285.00 | +18.8% | 247.91 |
| 8 Sept 2026 | Vertical Research | — | 255.00 | — | 237.72 |
| 6 Aug 2026 | Truist Financial | Reiterated · Buy | 303.00 → 316.00 | +4.3% | 255.23 |
| 5 Aug 2026 | Seaport Global Scott Graham | — | 240.00 → 290.00 | +20.8% | 255.81 |
| 5 Aug 2026 | RBC Capital Deane Dray | Reiterated · Outperform | 257.00 → 291.00 | +13.2% | 254.50 |
| 5 Aug 2026 | Robert W. Baird Quinn Fredrickson | — | 244.00 → 275.00 | +12.7% | 254.05 |
| 5 Aug 2026 | KeyBanc | Reiterated · Overweight | 235.00 → 295.00 | +25.5% | 254.05 |
| 10 Jul 2026 | Morgan Stanley | Reiterated · Equal Weight | 215.00 → 245.00 | +14.0% | 234.99 |
| 2 Jul 2026 | Truist Financial Jamie Cook | Reiterated · Buy | 275.00 → 303.00 | +10.2% | 237.13 |
| 18 Jun 2026 | Redburn Partners Richard Radbourne | — | 265.00 | — | 231.27 |
| 4 May 2026 | Truist Financial | Reiterated · Buy | 265.00 → 275.00 | +3.8% | 231.30 |
| 4 May 2026 | Barclays Julian Mitchell | Reiterated · Equal Weight | 220.00 → 230.00 | +4.5% | 230.48 |
| 1 May 2026 | Robert W. Baird Quinn Fredrickson | — | 245.00 → 244.00 | -0.4% | 231.98 |
| 1 May 2026 | Mizuho Securities | — | 235.00 → 270.00 | +14.9% | 232.62 |
| 26 Mar 2026 | BMO Capital Daniel DiCicco | — | 253.00 | — | 211.47 |
| 5 Feb 2026 | Robert W. Baird | — | 204.00 → 245.00 | +20.1% | 227.83 |
| 4 Feb 2026 | Truist Financial | — | 229.00 → 265.00 | +15.7% | 229.47 |
| 4 Feb 2026 | RBC Capital | — | 229.00 → 257.00 | +12.2% | 227.97 |
| 4 Feb 2026 | Mizuho Securities | — | 230.00 → 235.00 | +2.2% | 228.92 |
| 4 Feb 2026 | Barclays Julian Mitchell | Reiterated · Equal Weight | 210.00 → 220.00 | +4.8% | 228.92 |
| 27 Jan 2026 | Oppenheimer | Downgraded · Outperform → Perform | — | — | — |
| 21 Jan 2026 | Deutsche Bank | — | 271.00 | — | 213.14 |
| 12 Jan 2026 | Morgan Stanley Christopher Snyder | Reiterated · Equal Weight | 215.00 | — | 211.10 |
| 7 Jan 2026 | Barclays Julian Mitchell | Reiterated · Equal Weight | 205.00 → 210.00 | +2.4% | 214.16 |
| 6 Jan 2026 | KeyBanc | Reiterated · Overweight | 220.00 → 235.00 | +6.8% | 211.31 |
| 5 Jan 2026 | Melius Research Rob Wertheimer | — | 235.00 | — | 212.09 |
| 5 Jan 2026 | Mizuho Securities | Reiterated · Outperform | 212.00 → 230.00 | +8.5% | 209.14 |
| 23 Dec 2025 | TD Cowen | Upgraded · Hold → Buy | — | — | — |
| 8 Dec 2025 | D.A. Davidson | — | 240.00 | — | 199.92 |
Ametek EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Ametek's EPS to grow 17.3% a year until 2028, faster than over the last 5 years (11.2% a year) and the last 3 years (8.5%).
Analysts expect Ametek's revenue to grow 11.9% a year until 2028. Over the last 5 years it grew 10.3% a year, and over the last 3 years 6.4%.
Revenue
EPS
Does Ametek beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.7% off the result, either way, and their revenue estimate 2.4%, over the last 12 quarters.
- EPS beats
- 74 / 117
- Revenue beats
- 81 / 117
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.7%
- Since
- November 1997
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 3 Nov 2026 | 2.11 | 2.21 | +4.7% | 2.12B | 2.22B | +4.6% |
| Q2 FY2026 | 4 Aug 2026 | 1.99 | 2.09 | +5.0% | 1.95B | 2.04B | +4.6% |
| Q1 FY2026 | 30 Apr 2026 | 1.90 | 1.97 | +3.7% | 1.91B | 1.93B | +0.7% |
| Q4 FY2025 | 3 Feb 2026 | 1.94 | 2.01 | +3.6% | 1.95B | 2.00B | +2.7% |
| Q3 FY2025 | 30 Oct 2025 | 1.76 | 1.89 | +7.4% | 1.81B | 1.89B | +4.3% |
| Q2 FY2025 | 31 Jul 2025 | 1.69 | 1.78 | +5.3% | 1.73B | 1.78B | +2.5% |
| Q1 FY2025 | 1 May 2025 | 1.69 | 1.75 | +3.6% | 1.74B | 1.73B | -0.6% |
| Q4 FY2024 | 4 Feb 2025 | 1.85 | 1.87 | +1.1% | 1.82B | 1.76B | -3.2% |
| Q3 FY2024 | 31 Oct 2024 | 1.62 | 1.66 | +2.5% | 1.71B | 1.71B | -0.1% |
| Q2 FY2024 | 1 Aug 2024 | 1.64 | 1.66 | +1.2% | 1.78B | 1.73B | -2.6% |
| Q1 FY2024 | 2 May 2024 | 1.59 | 1.64 | +3.1% | 1.78B | 1.74B | -2.4% |
| Q4 FY2023 | 6 Feb 2024 | 1.63 | 1.68 | +3.1% | 1.73B | 1.73B | -0.2% |
Ametek stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Ametek's earnings keep growing at the 11.6% a year analysts expect to FY2028, it would earn about 12.84 a share in FY2030. At the P/E it has traded at over the last five years (27.7 to 34.3) that is 356.00 to 440.15 a share, or 396.62 at its average P/E of 30.9. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 8.53 | 236.47 | 263.45 | 292.37 |
| FY2027 | 9.61 | 266.40 | 296.80 | 329.37 |
| FY2028 | 10.32 | 286.02 | 318.65 | 353.63 |
| FY2029 (extrapolated) | 11.51 | 319.10 | 355.50 | 394.53 |
| FY2030 (extrapolated) | 12.84 | 356.00 | 396.62 | 440.15 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 11.6% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (27.7, 30.9, 34.3).
Is Ametek stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Ametek's P/E of 32.1 is above the middle of its 5-year range (23.6 to 37.6, median 29.7). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 1.9 on expected growth against 2.7 on its median P/E and past five years' growth. At its usual P/E (29.7 × EPS of 7.12), Ametek's fair value is 211.69; the price, 228.62, is 8.0% above it. Its forward P/E, on the consensus for FY2026, is 26.8.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (23.6 and 37.6). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 32.11
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 29.73
- Five-year P/E range
- 23.6 – 37.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 26.80
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.78
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +24.6%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 213.670 | 405.57304Price 213.67507 | +89.8% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.